Evaluation of Electronic Florbetapir (18F) Interpretation Training in Japanese Physicians

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

October 31, 2014

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Alzheimer's Disease
Interventions
DRUG

Florbetapir (18F)

No Florbetapir (18F) will be administered in this study.

Trial Locations (1)

100-0005

Research Site, Tokyo

Sponsors
All Listed Sponsors
lead

Avid Radiopharmaceuticals

INDUSTRY